Odaily Planet Daily News: Hong Kong listed company Navigating Pharmaceutical Biotechnology Co., Ltd. (00399) announced the signing of a memorandum of understanding, planning to acquire all equity of the target company, provided that the target company completes the acquisition of Conflux blockchain-related assets. The price of this acquisition will be paid through cash, company shares, or convertible bonds, with the specific amount to be determined in the formal agreement. The memorandum of understanding is valid for 12 months, during which time the seller shall not negotiate or transact with other parties regarding the equity of the target company. Navigating Pharmaceutical hopes to expand its business into the blockchain technology field through this acquisition, achieve business diversification, and seek new profit growth points. However, the transaction still needs to be formalized with a signed agreement, and relevant announcements will be made in a timely manner according to listing rules. Shareholders and investors should act with caution.